Pharmacokinetics and tolerability of two different formulations of budesonide/formoterol (Spiromax and Turbuhaler), with and without charcoal, in volunteers

Trial Profile

Pharmacokinetics and tolerability of two different formulations of budesonide/formoterol (Spiromax and Turbuhaler), with and without charcoal, in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Charcoal
  • Indications Asthma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Oct 2013 New trial record
    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top